A company with growing sales.
Facts from SEC filings, not a recommendation.
From AKTS's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $9.7M.
Move the sliders to your own view of AKTS. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 2.5% from their holdings. 78 bought, 24 sold.
No offerings, red flags or new big holders. Clean record.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
12,500 shares at $20.69 avg ($20.19 to $21.03) · $259K
4,856 shares at $24.56 · $119K
3,065 shares at $25.21 · $77K
50,000 shares at $27.77 avg ($27.13 to $28.71) · $1.4M
50,000 shares at $27.75 avg ($27.13 to $28.75) · $1.4M
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page